APA

Sieuwerts A. M., Look M. P., Meijer-van Gelder M. E., Timmermans M., Trapman A. M. A. C., Garcia R. R., Arnold M., Goedheer A. J. W., de Weerd V., Portengen H., Klijn J. G. M. & Foekens J. A. (20071109). Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Sieuwerts Anieta M, Look Maxime P, Meijer-van Gelder Marion E, Timmermans Mieke, Trapman Anita M A C, Garcia Roberto Rodriguez, Arnold Miranda, Goedheer Anneke J W, de Weerd Vanja, Portengen Henk, Klijn Jan G M and Foekens John A. 20071109. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Sieuwerts A. M., Look M. P., Meijer-van Gelder M. E., Timmermans M., Trapman A. M. A. C., Garcia R. R., Arnold M., Goedheer A. J. W., de Weerd V., Portengen H., Klijn J. G. M. and Foekens J. A. (20071109). Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Sieuwerts Anieta M, Look Maxime P, Meijer-van Gelder Marion E, Timmermans Mieke, Trapman Anita M A C, Garcia Roberto Rodriguez, Arnold Miranda, Goedheer Anneke J W, de Weerd Vanja, Portengen Henk, Klijn Jan G M and Foekens John A. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20071109.